Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.177.89EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
M.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.333EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.429EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.463EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
U.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.373EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.80EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.433EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.36.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.242EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.449EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.152EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.146EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.21 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EE.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.631EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.627EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.519EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.514EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DJ.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BW.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used